Sarcopenia as a Prognostic Factor for the Outcomes of Surgical Treatment of Colorectal Carcinoma
- PMID: 40218024
- PMCID: PMC11989190
- DOI: 10.3390/healthcare13070726
Sarcopenia as a Prognostic Factor for the Outcomes of Surgical Treatment of Colorectal Carcinoma
Abstract
Background/Objectives: Sarcopenia, defined as the progressive loss of muscle mass and function, is increasingly associated with worse outcomes in the surgical treatment of colorectal cancer (CRC). This paper focuses on analyzing the impact of sarcopenia as a prognostic factor on postoperative outcomes in CRC patients. The aim of the study is to identify the main factors influencing postoperative results. This will be accomplished via bibliometric analysis and highlighting the significance of muscle condition in the preoperative assessment of patients. Methods: The methodological approach involves analyzing bibliographic data from relevant scientific databases focused on sarcopenia and oncological surgery. The study employs a quantitative analysis of citations and collaborations among authors and institutions. The focus will be on research publications from 2013, when we first identified references to sarcopenia in the examined context. Results: The results show that sarcopenia significantly increases the risk of postoperative morbidity and mortality in CRC patients. Network analysis and keyword mapping reveal dominant research topics such as muscle condition, mortality, and postoperative complications. Meanwhile, we identify the need for standardized diagnostic methods for sarcopenia and their integration into clinical practice to improve predictive models and clinical approaches. Conclusions: These findings underscore the importance of interdisciplinary collaboration, preoperative assessment of muscle condition, and the implementation of standardized approaches to improve clinical outcomes for patients.
Keywords: bibliometric analysis; colorectal carcinoma; prognostic factor; sarcopenia; surgical treatment.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures












Similar articles
-
The impact of sarcopenia on morbidity and long-term survival among patients with peritoneal metastases of colorectal origin treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a 10-year longitudinal analysis of a single-center experience.Tech Coloproctol. 2020 Apr;24(4):301-308. doi: 10.1007/s10151-020-02159-z. Epub 2020 Feb 21. Tech Coloproctol. 2020. PMID: 32080800
-
A new diagnostic index for sarcopenia and its association with short-term postoperative complications in patients undergoing surgery for colorectal cancer.Colorectal Dis. 2019 May;21(5):538-547. doi: 10.1111/codi.14558. Epub 2019 Feb 4. Colorectal Dis. 2019. PMID: 30648340
-
Clinical Impact of Muscle Quantity and Quality in Colorectal Cancer Patients: A Propensity Score Matching Analysis.JPEN J Parenter Enteral Nutr. 2018 Nov;42(8):1322-1333. doi: 10.1002/jpen.1171. Epub 2018 May 15. JPEN J Parenter Enteral Nutr. 2018. PMID: 29761898
-
Low skeletal muscle mass and postoperative morbidity in surgical oncology: a systematic review and meta-analysis.J Cachexia Sarcopenia Muscle. 2020 Jun;11(3):636-649. doi: 10.1002/jcsm.12529. Epub 2020 Mar 3. J Cachexia Sarcopenia Muscle. 2020. PMID: 32125769 Free PMC article.
-
Impact of sarcopenia on outcomes in surgical patients: a systematic review and meta-analysis.Int J Surg. 2023 Dec 1;109(12):4238-4262. doi: 10.1097/JS9.0000000000000688. Int J Surg. 2023. PMID: 37696253 Free PMC article.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources